News
NIH is issuing an Intramural Research Program (IRP) policy to promote access to IRP-supported inventions resulting in drugs, biologics, vaccines, or devices. As of June 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to submit Access Plans to NIH
The Center for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH) have found that adding in an air-bubble cushioning liner substantially improves a helmet’s shock absorption performance at high impact forces. Helmets are used to protect against
NIH IRP Senior Investigator and Inventor Heinz Feldmann, M.D., was elected to the National Academy of Medicine (NAM). Dr. Feldmann is the chief of the Laboratory of Virology at the National Institute of Allergy and Infectious Diseases (NIAID). He led the development of the technology that resulted
Join Michael Salgaller, NCI Invention Development and Marketing Unit, and Steven Ferguson, OTT Special Advisor, for a presentation on Technology Development and Commercialization: Impacting Pipelines and Bottom Lines. They will be speaking at the Therapeutics Area Partnerships (TAP) Oncology